Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice.
Sangsu BangChristopher R DonnellyXin LuoMaria ToroXueshu TaoZilong WangSharat ChandraAndrey V BortsovEmily R DerbyshireRu-Rong JiPublished in: Nature communications (2021)
GPR37 was discovered more than two decades ago, but its biological functions remain poorly understood. Here we report a protective role of GPR37 in multiple models of infection and sepsis. Mice lacking Gpr37 exhibited increased death and/or hypothermia following challenge by lipopolysaccharide (LPS), Listeria bacteria, and the mouse malaria parasite Plasmodium berghei. Sepsis induced by LPS and Listeria in wild-type mice is protected by artesunate (ARU) and neuroprotectin D1 (NPD1), but the protective actions of these agents are lost in Gpr37-/- mice. Notably, we found that ARU binds to GPR37 in macrophages and promotes phagocytosis and clearance of pathogens. Moreover, ablation of macrophages potentiated infection, sepsis, and their sequelae, whereas adoptive transfer of NPD1- or ARU-primed macrophages reduced infection, sepsis, and pain-like behaviors. Our findings reveal physiological actions of ARU in host cells by activating macrophages and suggest that GPR37 agonists may help to treat sepsis, bacterial infections, and malaria.
Keyphrases
- septic shock
- wild type
- acute kidney injury
- intensive care unit
- fatty acid
- high fat diet induced
- plasmodium falciparum
- chronic pain
- inflammatory response
- induced apoptosis
- signaling pathway
- type diabetes
- mesenchymal stem cells
- skeletal muscle
- spinal cord
- neuropathic pain
- adipose tissue
- pain management
- genome wide
- brain injury
- gene expression
- high glucose
- metabolic syndrome
- toll like receptor
- cell death
- spinal cord injury
- oxidative stress
- drug induced
- endoplasmic reticulum stress
- endothelial cells
- cell cycle arrest